Sepracor to become Sunovion Pharmaceuticals
Sepracor Inc., the Marlborough drug company perhaps best known for its Lunesta sleep aid, will be renamed Sunovion Pharmaceuticals Inc. in the United States following its recent purchase by Dainippon Sumitomo Pharma Co. Ltd. of Japan.
Dainippon Sumitomo acquired Sepracor in October, and the name change is planned to occur in anticipation of the one-year anniversary of the acquisition, the companies said in a press release. "Sepracor intends to begin officially operating as Sunovion Pharmaceuticals Inc. before the end of 2010."
"In order to foster a sense of unity for our combined US operations, we have decided that we will change its (Sepracor's) name," Masayo Tada, president and chief executive of Dainippon Sumitomo, said in a statement. "Moreover, we intend to expand the Sunovion brand in certain strategic international locations."
As Sunovion Pharmaceuticals., Sepracor will retain its corporate headquarters in Marlborough, the release added.